Scholarlink

<p>Diabetic kidney disease (DKD) is a significant consequence of diabetes, markedly contributing to the global burden of end-stage renal disease (ESRD). DKD, a substantial public health challenge, is characterized by elevated urinary albumin excretion and/or reduced glomerular filtration rate. As the primary cause of end-stage renal disease (ESRD), comprehending the prevalence of DKD and investigating relevant biomarkers for diagnosis is imperative. The pathogenesis of DKD is intricate, involving both genetic and epigenetic factors. Among these factors, DNA methylation has surfaced as a pivotal element, offering insights into the progression of DKD and potential therapeutic targets. This review endeavors to synthesize current research on DNA methylation biomarkers in DKD, emphasizing advances and potential clinical applications.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

DNA methylation biomarkers in diabetic kidney disease: insights and implications

  • 期刊论文

  • 发表日期：

    2025年7月30日

查看全文
  • Ziyi Feng,
  • Xiaomu Kong,
  • Liang Ma

摘要

Diabetic kidney disease (DKD) is a significant consequence of diabetes, markedly contributing to the global burden of end-stage renal disease (ESRD). DKD, a substantial public health challenge, is characterized by elevated urinary albumin excretion and/or reduced glomerular filtration rate. As the primary cause of end-stage renal disease (ESRD), comprehending the prevalence of DKD and investigating relevant biomarkers for diagnosis is imperative. The pathogenesis of DKD is intricate, involving both genetic and epigenetic factors. Among these factors, DNA methylation has surfaced as a pivotal element, offering insights into the progression of DKD and potential therapeutic targets. This review endeavors to synthesize current research on DNA methylation biomarkers in DKD, emphasizing advances and potential clinical applications.